For the month of March 2025

 

 

(Translation of registrant’s name into English)

 

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒

Form 40-F ☐

 

 

Exhibit Number	Description
99.1	21 March 2025 - “Completion of off-market purchase and Total Voting”

 

 

 

 

99.1

 

Haleon plc: Completion of off-market purchase and Total Voting Rights and Capital

 

21 March 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that it has completed the off-market purchase of 44,155,844 ordinary shares of £0.01 each, repurchased from Pfizer Inc. for an aggregate purchase price of approximately £170 million. The purchased ordinary shares have been cancelled.

 

As at 21 March 2025, the total number of ordinary shares issued by Haleon is 9,039,570,075, of which 4,080,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 9,035,489,870 and this figure may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

Amanda Mellor 

Company Secretary 

 

 

Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Emma White	+44 7823 523562
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

 

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

 

For more information please visit www.haleon.com

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

		HALEON PLC (Registrant)
Date: March 21, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary